{"data":{"investorProfile":{"id":4601411,"userId":5107969,"url":"/luke.bayliss","profilePictureUrl":"https://wefunder.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTgyODc1MiwicHVyIjoiYmxvYl9pZCJ9fQ==--25ceb9a214c4f7a54123c4254e6f96192b40a309/eyJfcmFpbHMiOnsiZGF0YSI6eyJmb3JtYXQiOiJwbmciLCJyZXNpemVfdG9fZmlsbCI6WzE1MCwxNTBdfSwicHVyIjoidmFyaWF0aW9uIn19--7348f7de593deefc72b995d981f4d9590c736124/profile_picture_d8c92fdaf60e.png","profilePictureXlUrl":"https://wefunder.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsiZGF0YSI6MTgyODc1MiwicHVyIjoiYmxvYl9pZCJ9fQ==--25ceb9a214c4f7a54123c4254e6f96192b40a309/eyJfcmFpbHMiOnsiZGF0YSI6eyJmb3JtYXQiOiJwbmciLCJyZXNpemVfdG9fZmlsbCI6WzUwMCw1MDBdfSwicHVyIjoidmFyaWF0aW9uIn19--83125bf6ceb0e77871098cc74f0d5e2838d441ae/profile_picture_d8c92fdaf60e.png","fullName":"Luke Bayliss","firstName":"Luke","username":"lukebayliss","kycVerified":true,"verifiedAccredited":false,"bio":"I'm a UK-based investor focused on backing ambitious founders building the next generation of technology companies. I invest across AI, deep-tech, healthcare, climate technology, robotics, and advanced manufacturing, with a particular interest in business","website":"","twitterUrl":null,"twitterName":null,"linkedinUrl":null,"linkedinName":null,"usAddress":false,"city":"Hove","state":null,"region":"England","joinedAt":"May 2026","angelInvestmentAmountPerStartupRange":{"min":null,"max":null},"followerCount":8,"followingCount":24,"companies":[],"syndicates":[],"portfolio":[{"id":1971683,"logo":"//uploads.wefunder.com/uploads/company/logo/188422/medium_avatar.jpg","companyId":188422,"companyName":"Rejuvenate Bio","companyTagline":"Reversing age-related decline — proven in animals, advancing to humans","topFact":"Led by exited biotech entrepreneurs from Harvard, MIT, Duke, Princeton, and Caltech","companyUrl":"https://wefunder.com/rejuvenatebio","confirmedInvestmentDateRaw":"2026-06-23T21:02:34.745Z","confirmedInvestmentDate":"June 2026","offPlatform":false,"noLink":false,"isActivelyFundraising":true,"matchedCompanyId":null,"hasAvatar":false},{"id":1968609,"logo":"//uploads.wefunder.com/uploads/company/logo/168070/medium_blob.jpeg","companyId":168070,"companyName":"Biostate AI","companyTagline":"General-purpose biomedical AI working to help 90% of people live to 90","topFact":"$20M raised from leading VCs including Accel, Matter Venture Partners, InfoEdge Ventures, Vision Plus, and Caltech Fund.","companyUrl":"https://wefunder.com/biostate.ai","confirmedInvestmentDateRaw":null,"confirmedInvestmentDate":null,"offPlatform":false,"noLink":false,"isActivelyFundraising":true,"matchedCompanyId":null,"hasAvatar":false}],"thesis":null,"about":null,"interests":[{"id":72903,"presentableName":"B2C","exploreUrl":"/explore/b2c"},{"id":72906,"presentableName":"Service","exploreUrl":"/explore/service"},{"id":72908,"presentableName":"Technology","exploreUrl":"/explore/technology"},{"id":72909,"presentableName":"Fintech & Finance","exploreUrl":"/explore/fintech_and_finance"},{"id":72910,"presentableName":"Blockchain & Web3","exploreUrl":"/explore/blockchain_and_web3"},{"id":72912,"presentableName":"Retail","exploreUrl":"/explore/retail"},{"id":72918,"presentableName":"Home Tech","exploreUrl":"/explore/home_tech"},{"id":72919,"presentableName":"Biotech","exploreUrl":"/explore/biotech"},{"id":72920,"presentableName":"Robotics","exploreUrl":"/explore/robotics"},{"id":72921,"presentableName":"Marketplace","exploreUrl":"/explore/marketplace"},{"id":72922,"presentableName":"PBC & B Corp","exploreUrl":"/explore/pbc_and_b_corp"},{"id":72923,"presentableName":"Y Combinator","exploreUrl":"/explore/y_combinator"},{"id":72925,"presentableName":"B2B","exploreUrl":"/explore/b2b"},{"id":72926,"presentableName":"Healthcare","exploreUrl":"/explore/healthcare"},{"id":72927,"presentableName":"SaaS","exploreUrl":"/explore/saas"},{"id":72929,"presentableName":"Food & Beverage","exploreUrl":"/explore/food_and_beverage"},{"id":72930,"presentableName":"Hardware","exploreUrl":"/explore/hardware"},{"id":72931,"presentableName":"Ecommerce","exploreUrl":"/explore/ecommerce"},{"id":72932,"presentableName":"AR & VR","exploreUrl":"/explore/ar_and_vr"},{"id":72933,"presentableName":"Consumer Goods","exploreUrl":"/explore/consumer_goods"},{"id":72934,"presentableName":"Travel & Tourism","exploreUrl":"/explore/travel_and_tourism"},{"id":72937,"presentableName":"AI","exploreUrl":"/explore/artificial_intelligence"},{"id":72938,"presentableName":"Subscription","exploreUrl":"/explore/subscription"},{"id":72939,"presentableName":"Climate Change","exploreUrl":"/explore/climate_change"},{"id":72941,"presentableName":"Transportation","exploreUrl":"/explore/transportation"},{"id":72945,"presentableName":"Food Tech","exploreUrl":"/explore/food_tech"},{"id":72946,"presentableName":"Moonshots","exploreUrl":"/explore/moonshots"},{"id":72947,"presentableName":"Energy","exploreUrl":"/explore/energy"},{"id":72950,"presentableName":"Science & R&D","exploreUrl":"/explore/science_and_r_and_d"},{"id":72951,"presentableName":"Real Estate","exploreUrl":"/explore/real_estate"},{"id":72954,"presentableName":"Devtools","exploreUrl":"/explore/devtools"},{"id":72955,"presentableName":"Sustainability","exploreUrl":"/explore/sustainability"},{"id":72956,"presentableName":"Infrastructure & Construction","exploreUrl":"/explore/infrastructure_and_construction"},{"id":72957,"presentableName":"Manufacturing","exploreUrl":"/explore/manufacturing"},{"id":72960,"presentableName":"Agriculture & Agtech","exploreUrl":"/explore/agriculture_and_agtech"},{"id":72961,"presentableName":"Clean Tech","exploreUrl":"/explore/clean_tech"},{"id":72963,"presentableName":"Sports Tech","exploreUrl":"/explore/sports_tech"}],"helpTags":["leave_reviews","check_products_in_store","complete_a_user_interview"],"customHelpTags":[],"editProfileUrl":"/settings/public_profile","addOffPlatformInvestmentUrl":null,"adminOnlyUrl":null,"loginAsUrl":null,"privateInvestor":false,"privateLocation":false,"badges":[],"coinvestors":{"totalAmount":0,"totalCount":0},"mutualFollowers":{"totalCount":0,"previews":[]},"reviews":[{"personalMessage":"I'm excited to invest in Rejuvenate Bio because it combines exceptional asymmetric upside with a highly credible scientific and commercial strategy.

What attracted me most is that the company isn't simply pursuing longevity as a long-term research project. Instead, they're taking a practical route to market by targeting serious diseases in companion animals first, which provides a faster path to validation, revenue and real-world data while building toward much larger human applications.

The potential market is enormous. If Rejuvenate Bio succeeds in developing therapies that meaningfully extend healthy lifespan or treat age-related diseases, the impact could be transformational across both veterinary and human healthcare. Few startups I've reviewed have the same combination of market size and potential societal impact.

I also like the strength of the scientific team and the quality of the investors involved. Gene therapy is one of the most technically demanding fields in biotech, so founder quality and scientific credibility are critical. Rejuvenate Bio appears to have both.

From an investment perspective, I focus heavily on asymmetric opportunities—companies where the upside significantly outweighs the downside. Rejuvenate Bio fits that profile extremely well. While the risks are high, as they are with any early-stage biotech company, the potential rewards if the technology succeeds are substantial.

For me, this is the type of startup that has the potential to become a category-defining company over the next decade, which is why I'm excited to be an investor.","company":"Rejuvenate Bio","date":"2026-06-13T11:45:19.241Z","url":"/rejuvenatebio","logo":"//uploads.wefunder.com/uploads/company/logo/188422/medium_avatar.jpg"},{"personalMessage":"I'm investing because Biostate AI sits at the intersection of two huge long-term trends: AI and genomics. The company is building technology that could dramatically reduce the cost of RNA sequencing and create a large proprietary biological dataset. If they execute successfully, that data could become extremely valuable for drug discovery, diagnostics, and precision medicine. It's a high-risk investment, but I think the potential upside is asymmetric compared to the amount I'm investing.","company":"Biostate AI","date":"2026-06-06T18:38:57.116Z","url":"/biostate.ai","logo":"//uploads.wefunder.com/uploads/company/logo/168070/medium_blob.jpeg"}],"showActivity":false},"currentUser":{"id":null,"isOwner":false,"canPostToProfile":false,"isAdmin":null,"adminLoginAsUrl":null,"emailUnfollow":false,"autoFollow":false,"follow":{"isFollower":null,"isCoinvestor":null,"amount":null,"presentableAmount":null}},"ahoyEventData":{"followInvestorProfileEventName":"follow_investor_profile","unfollowInvestorProfileEventName":"unfollow_investor_profile","investorCardProfileComponentProperty":"investor_card_profile","coinvestWithInvestorProfileEventName":"coinvest_with_investor_profile","stopCoinvestWithInvestorProfileEventName":"stop_coinvest_with_investor_profile","followVersionA":"A","altLocation":"investor_profile"}}}

Luke Bayliss

Recent investments

Related profile links